BRIEF published on 08/04/2025 at 14:05, 6 months 10 days ago Medincell Annonce son Assemblée Générale 2025 Gouvernance Assemblée Générale Resolutions Medincell Rémunérations
BRIEF published on 08/04/2025 at 14:05, 6 months 10 days ago Medincell Announces its 2025 General Meeting Governance General Meeting Resolutions Remuneration Medincell
PRESS RELEASE published on 08/04/2025 at 14:00, 6 months 10 days ago Informations privilégiées / Autres communiqués Medincell publie la convocation pour son assemblée générale annuelle mixte 2025, incluant des résolutions sur les comptes, l'approbation des dirigeants et des délégations au Conseil d'administration Assemblée Générale Convocation Resolutions Pharmaceutique Medincell
BRIEF published on 07/30/2025 at 14:34, 6 months 15 days ago Chiffre d'affaires croissant de Medincell et prochaines soumissions Traitement De La Schizophrénie Chiffre D'affaires De Medincell Ventes UZEDY Soumission D'olanzapine Partenariat Teva
BRIEF published on 07/30/2025 at 14:34, 6 months 15 days ago Medincell's Rising Revenue and Upcoming Submissions Schizophrenia Treatment Teva Partnership Medincell Revenue UZEDY Sales Olanzapine Submission
PRESS RELEASE published on 07/30/2025 at 14:32, 6 months 15 days ago INFORMATIONS PRIVILÉGIÉES / AUTRES COMMUNIQUÉS Medincell accélère avec des prévisions de ventes 2025 relevées pour UZEDY® et confirmation de la demande de mise sur le marché américain pour l'Olanzapine LAI Schizophrénie Medincell Teva Pharmaceuticals Olanzapine LAI UZEDY
PRESS RELEASE published on 07/30/2025 at 14:29, 6 months 15 days ago INSIDE INFORMATION / OTHER NEWS RELEASES Medincell's partner Teva Pharmaceuticals raises 2025 revenue outlook for UZEDY® to $190–$200M and confirms Olanzapine LAI on track for submission in 2025 Revenue Outlook Medincell Teva Pharmaceuticals Olanzapine LAI Submission
BRIEF published on 07/30/2025 at 13:47, 6 months 15 days ago Les prévisions de résultats financiers prometteurs pour les médicaments UZEDY® et Olanzapine LAI de Medincell Traitement De La Schizophrénie Teva Pharmaceuticals Prévisions De Revenus De Medincell Performances UZEDY® Développement De L'olanzapine LAI
BRIEF published on 07/30/2025 at 13:47, 6 months 15 days ago Medincell's UZEDY® and Olanzapine LAI Forecast Promising Financial Outcomes Schizophrenia Treatment Teva Pharmaceuticals Medincell Revenue Forecast UZEDY® Performance Olanzapine LAI Development
PRESS RELEASE published on 07/30/2025 at 13:42, 6 months 15 days ago Inside Information / Other news releases Medincell's partner Teva increases 2025 revenue outlook for UZEDY® to $190–$200M, plans olanzapine LAI submission. Company's innovative treatments aim to improve medicine accessibility Revenue Outlook Medincell Teva Pharmaceuticals Olanzapine LAI UZEDY
Published on 02/14/2026 at 01:00, 1 day 6 hours ago Orogen Royalties Announces Annual Equity Compensation Grant
Published on 02/13/2026 at 22:15, 1 day 9 hours ago Storm Completes Sale of Miminiska Project for $5.8M and Outlines Plans for 2026
Published on 02/13/2026 at 17:45, 1 day 13 hours ago Eldorado Gold Closes $2.4 Million Strategic Investment in Gemdale Gold
Published on 02/13/2026 at 14:35, 1 day 17 hours ago Datametrex Received $500,000 Purchase Order For Data Centre Solutions
Published on 02/14/2026 at 16:30, 15 hours 9 minutes ago Milano Cortina 2026 Licensed Candies Released Globally
Published on 02/14/2026 at 06:05, 1 day 1 hour ago The 139th Canton Fair Promotion Conferences to Be Held in Germany and Morocco, Highlighting Targeted Industry Opportunities
Published on 02/13/2026 at 19:20, 1 day 12 hours ago Retail offering successfully completed and update on Euronext Growth Oslo listing
Published on 02/13/2026 at 19:01, 1 day 12 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/13/2026 at 18:20, 1 day 13 hours ago GLOBAL TECHNOLOGY LEADERS LAUNCH TRUSTED TECH ALLIANCE
Published on 02/13/2026 at 18:05, 1 day 13 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/01/2026
Published on 02/13/2026 at 18:05, 1 day 13 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/01/2026
Published on 02/13/2026 at 17:50, 1 day 13 hours ago Number of shares and voting rights - January 2026 (In French only)
Published on 02/13/2026 at 17:50, 1 day 13 hours ago Nombre total d'actions et droits de vote - janvier 2026
